deltatrials
Completed OBSERVATIONAL NCT04991077

Interrupters of VAscular daMAge in Malignant Hypertension (IVAMA)

Interrupters of VAscular daMAge in Malignant Hypertension: Role of Inflammasome, Angiogenic and Vasoactive System

Sponsor: Centre Hospitalier de PAU

Conditions Malignant Hypertension
Interventions analyse of angiogenic, vasoactive and VEGF systems
Updated 8 times since 2021 Last updated: Oct 29, 2024 Started: Feb 7, 2022 Primary completion: Oct 11, 2024 Completion: Oct 11, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Malignant Hypertension, this trial is completed. The trial is conducted by Centre Hospitalier de PAU and has accumulated 8 data snapshots since 2022. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Apr 2022 · 4 months · monthly snapshot~Apr 2022 – ~May 2023 · 13 months · monthly snapshotRecruiting~May 2023 – ~Mar 2024 · 10 months · monthly snapshotRecruiting~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – present · 20 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Nov 2024 — Present [monthly]

    Completed

    Status: Recruiting → Completed

  2. Sep 2024 — Nov 2024 [monthly]

    Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  4. Mar 2024 — Jul 2024 [monthly]

    Recruiting

  5. May 2023 — Mar 2024 [monthly]

    Recruiting

▶ Show 3 earlier versions

  1. Apr 2022 — May 2023 [monthly]

    Recruiting

    Status: Not Yet Recruiting → Recruiting

  2. Dec 2021 — Apr 2022 [monthly]

    Not Yet Recruiting

  3. Sep 2021 — Dec 2021 [monthly]

    Not Yet Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centre Hospitalier de PAU
Data source: Centre Hospitalier de PAU

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations